University of Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, Chicago, IL, USA.
Cornea. 2012 Jul;31(7):844-5. doi: 10.1097/ICO.0b013e31822fff1a.
To report the use of a Boston type I keratoprosthesis as a primary penetrating procedure to treat gelatinous drop-like corneal dystrophy (GDLD), with presentation of pathologic findings and discussion of other surgical options.
A 49-year-old woman with GDLD in both eyes and history of recurrent corneal opacification following multiple superficial keratectomies is presented. Best corrected visual acuity (BCVA) was counting fingers in both eyes. A Boston type I keratoprosthesis was implanted in her left eye after optical iridectomy, extracapsular cataract extraction, and anterior vitrectomy.
The surgery was uneventful and one month after surgery, best corrected vision improved to 20/20 and has been maintained for a period of more than 14 months. No post-operative complications were observed. Histopathology of the corneal specimen is presented.
GDLD is a rare disorder of amyloid deposition. Recurrence of this condition following surgery is extremely common. Boston type I keratoprosthesis is an effective procedure for restoring vision in affected patients.
报告使用 Boston Ⅰ型角膜镜作为原发性穿透性手术治疗胶状滴状角膜营养不良(GDLD)的情况,介绍病理发现并讨论其他手术选择。
一名 49 岁女性,双眼均患有 GDLD,曾多次行浅层角膜切除术,反复出现角膜混浊。双眼最佳矫正视力(BCVA)均为指数。左眼行光学虹膜切除术、囊外白内障摘除术和前段玻璃体切除术,植入 Boston Ⅰ型角膜镜。
手术过程顺利,术后 1 个月,最佳矫正视力提高至 20/20,且已维持 14 个月以上。未观察到术后并发症。角膜标本的组织病理学检查结果。
GDLD 是一种罕见的淀粉样物质沉积症。术后该疾病复发极为常见。Boston Ⅰ型角膜镜是恢复受影响患者视力的有效方法。